The University of Kansas Cancer Center — Fairway, Kansas

Public research footprint of The University of Kansas Cancer Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Carcinoma, Non-Small-Cell Lung · Metastatic Bladder Large Cell Neuroendocrine Carcinoma · Locally Advanced Urothelial Carcinoma · Metastatic Malignant Solid Neoplasm

Recently updated registry entries

NCT03914300 — Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for… (Active Not Recruiting)
NCT03233711 — Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage… (Active Not Recruiting)
NCT03793179 — Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The University of Kansas Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.